Success Metrics

Active Trials
5(100%)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

5

all time

Status Distribution
Active(5)

Detailed Status

Recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
5
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 13 (60.0%)
Phase 22 (40.0%)

Trials by Status

active_not_recruiting120%
recruiting480%

Recent Activity

5 active trials
Showing 5 of 5
active_not_recruitingphase_2

Study of ZG005 in Patients With Advanced Solid Tumors

NCT06927687
recruitingphase_1

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

NCT06903377
recruitingphase_1

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

NCT06883526
recruitingphase_1

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

NCT06938880
recruitingphase_2

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

NCT06558227

Clinical Trials (5)

Showing 5 of 5 trials
NCT06927687Phase 2

Study of ZG005 in Patients With Advanced Solid Tumors

Active Not Recruiting
NCT06903377Phase 1

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

Recruiting
NCT06883526Phase 1

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

Recruiting
NCT06938880Phase 1

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Recruiting
NCT06558227Phase 2

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5